Johnson & Johnson - Index

Johnson & Johnson - report - Index

ABOUT JOHNSON & JOHNSON
Johnson & Johnson is the world’s most comprehensive and
broadly based manufacturer of health care products, as well as
a provider of related services, for the consumer, pharmaceutical,
and medical devices and diagnostics markets. Headquartered
in New Brunswick, NJ, we are a family of more than 250
operating companies employing approximately 119,200 men
and women in 57 countries. Listed on the New York Stock
Exchange since 1944, under the symbol JNJ, the Company
had $61.1 billion in worldwide sales during 2007.
Johnson & Johnson is organized on the principles of
decentralized management, diversification in health care,
Customers
Access to healthcare
Intellectual property
Counterfeit products
External manufacturing
Supply chain management
Advanced technologies
Research & development
Animal welfare
Health care compliance
HIV/AIDS drugs
Product stewardship
FACTS
The Company has
issued dividends to
shareholders every
quarter since 1944.
OUR BUSINESS SEGMENTS
OUR STRATEGIC PRINCIPLES
Broadly based in human health care
Managed for the long term
Decentralized management approach
Employees
Safety performance
Ergonomics
Knowledge management
Diversity
Global wellness program
HIV/AIDS initiative
Freedom of association
Employee assistance
Flexible work arrangements
Tobacco-free workplaces
People and values
OUR STAKEHOLDERS AND THEIR INTERESTS
Dividends have been
raised each year for
45 consecutive years.
long-term perspectives, and shared values across our businesses.
Our Credo, written more than 60 years ago (see back cover)
articulates our responsibilities to patients, customers, employees,
communities and shareholders and inspires us to make a
positive difference in the world. It serves as the framework for
our sustainability strategy and activities. Most importantly,
in a decentralized management structure, the Credo unifies
our employees. Throughout our many business dealings,
when a course of action is not immediately clear, we look to
Our Credo to guide our decision-making. Johnson & Johnson
is still remembered today for its decisions at the time of the
TYLENOL® product tampering, but everyday in less dramatic
ways, these same values are applied everywhere we operate.
Community
Supplier diversity
Forest products purchasing
Nursing shortage
Climate change
Charitable contributions
Partnerships
Biodiversity & conservation
Environmental literacy
Environmental performance
Packaging
Transparency
Benchmarking
Sales have increased
each year for
75 consecutive years.
Shareholders
Financial performance
Governance
Business conduct
Business continuity
Public policy
The Company has
had adjusted earnings
increases for
24 consecutive years.
3